| Natalie Nelson, | |
|
2200 Childrens Way, Nashville, TN 37232-0005 | |
| (615) 322-0536 | |
| Not Available |
| Full Name | Natalie Nelson |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Neonatal |
| Location | 2200 Childrens Way, Nashville, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710366174 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SN0000X | Clinical Nurse Specialist - Neonatal | 19959 (Tennessee) | Secondary |
| 363LN0000X | Nurse Practitioner - Neonatal | APN19959 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Natalie Nelson, 3601 Tvc, Nashville, TN 37232-0001 Ph: (615) 322-3000 | Natalie Nelson, 2200 Childrens Way, Nashville, TN 37232-0005 Ph: (615) 322-0536 |
News Archive
BioVex Inc, a biotechnology company developing clinical stage treatments for cancer and the prevention of infectious disease, announced today that the U.S. Food and Drug Administration (FDA) has approved the design of a single, pivotal, Phase III clinical trial evaluating its lead product, OncoVEX (GM-CSF), for the first-line treatment of patients with squamous cell cancer of the head and neck.
The retirement announcements from Sen. Byron Dorgan (D-N.D.) and Sen. Chris Dodd (D-Conn.) [are] unlikely have a direct impact on the final push for health care legislation, Democratic and health care insiders said Wednesday.
Oral cancer is a common condition affecting over 30,000 Americans each year. Worldwide the number falls into the hundreds of thousands, and a significant percentage of those with oral cancer end up losing teeth and normal mouth function in the absence of early cancer detection and treatment.
Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced it has launched new education, distribution, sampling and reimbursement programs for TIMOPTIC(R) in OCUDOSE(R), the only preservative-free medication for glaucoma available in the United States. Aton acquired the U.S. marketing rights in February to the TIMOPTIC product line from Merck & Co., Inc. TIMOPTIC (timolol maleate) is a non-selective beta-adrenergic receptor blocking agent indicated for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. As many as 2.25 million Americans suffer from open-angle glaucoma.
› Verified 9 days ago
Rosie K Blakemore, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Tennessee Prison For Women, 3881 Stewarts Lane, Nashville, TN 37243 Phone: 615-741-1255 Fax: 615-726-2181 | |
Daniel Barrett, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3601 Tvc, Nashville, TN 37232 Phone: 615-322-3000 | |
Jacquelyn L. Garner, PNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
Ms. Rose B Vick, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
Aaron Wesley Scott, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-936-2000 | |
Gold Nwokochah, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2805 Foster Ave Ste 207, Nashville, TN 37210 Phone: 206-554-1900 | |
Ms. Leslie Elizabeth Newman, NNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-936-2000 |